Related Experiment Video
Updated: Jun 10, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Hypertension in end-stage renal disease: different measures and their prognostic significance
1Division of Nephrology and Dialysis, Department of Medicine III, University of Vienna, Vienna, Austria. Walter.hoerl@meduniwien.ac.at
Insights
Maintaining normal fluid balance (normovolaemia) is crucial for managing high blood pressure (hypertension) in haemodialysis patients. Strict volume control through methods like ultrafiltration and salt restriction can reduce or eliminate the need for blood pressure medications.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Hypertension is a significant risk factor for cardiovascular morbidity and mortality.
- The majority of haemodialysis (HD) patients experience hypertension.
- Accurate blood pressure (BP) assessment and target levels in HD patients lack sufficient prospective data.
Purpose of the Study:
- To emphasize normovolaemia as the primary therapeutic target in haemodialysis patients.
- To discuss non-pharmacological strategies for managing hypertension in HD patients.
- To highlight the need for further research on optimal BP targets and treatments.
Main Methods:
- Focus on achieving normovolaemia through dry-weight reduction via additional ultrafiltration.
- Implementing daily dietary salt restriction or individually lowered dialysate sodium.
- Considering alternative HD modalities like long, slow home HD, frequent short HD, or nocturnal HD.
Main Results:
- Strict volume control can significantly reduce or eliminate the need for antihypertensive drug treatment.
- Alternative HD modalities have shown potential in reducing BP and left ventricular hypertrophy.
- Prospective data is limited, necessitating further investigation.
Conclusions:
- Normovolaemia is the key therapeutic target for managing hypertension in haemodialysis patients.
- Non-pharmacological interventions, particularly strict volume control, are effective.
- Further research is required to establish optimal BP targets and therapeutic strategies.
Abstract:
Hypertension is a risk factor for cardiovascular morbidity and mortality. Hypertension affects the majority of haemodialysis (HD) patients. However, in the absence of prospective data, accurate assessment of blood pressure (BP) and the level to which BP should be targeted remain still to be defined. A direct relationship between volume status and BP as well as between hypervolaemia and morbidity and mortality in HD patients indicates that normovolaemia is the key therapeutic target. Dry-weight reduction by additional ultrafiltration (even in the absence of clinical signs of volume overload) combined with daily dietary salt restriction or individually lowered dialysate sodium is recommended. Strict volume control allows marked reduction of antihypertensive drug treatment or makes it even unnecessary. Long, slow, home HD or frequent, short HD sessions or nocturnal HD also result in reduction of BP and left ventricular hypertrophy in end-stage renal disease patients. It will be interesting to see which recommendations will come from a conference sponsored by the Kidney Disease: Improving Global Outcomes on optimal BP treatment target in relation to end-organ damage and outcomes in HD patients, on antihypertensive drugs and on non-pharmacological therapies are to be considered in achieving BP targets in this population based on a paucity of prospective data.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Chronic Kidney Disease III: Interprofessional Care
Hypertension and Regulation of Blood Pressure
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Chronic Kidney Disease I: Introduction
Diabetic Nephropathy